| DRGYX | RMFCX | DRGYX / RMFCX | |
| Total Expense Ratio | 0.64 | 0.91 | 70% |
| Annual Report Gross Expense Ratio | 0.64 | 0.91 | 70% |
| Fund Existence | 12 years | 23 years | - |
| Gain YTD | 15.895 | 15.796 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.1B | 113B | 9% |
| Annual Yield % from dividends | 1.06 | 1.21 | 88% |
| Returns for 1 year | 0.32 | 6.13 | 5% |
| Returns for 3 years | 19.90 | 28.94 | 69% |
| Returns for 5 years | 38.63 | 53.79 | 72% |
| Returns for 10 years | 36.11 | 89.93 | 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| REFGX | 8.71 | 0.09 | +1.04% |
| Emerging Markets Equities Fund R-6 | |||
| VSMPX | 305.44 | 2.10 | +0.69% |
| Vanguard Total Stock Mkt Idx Instl Pls | |||
| FBIOX | 25.83 | 0.17 | +0.66% |
| Fidelity Select Biotechnology | |||
| MDVZX | 9.10 | 0.05 | +0.55% |
| Manning & Napier Disciplined Value Z | |||
| TFFCX | 73.48 | 0.20 | +0.27% |
| Touchstone Focused C | |||